Products · Proof-first · Consequential boundaries

Start where consequence begins.

Meridian Verity products are narrow entry points into one fail-closed control architecture. Choose runtime action, conformance, or clinical reliance. Prove PASS / HOLD / FAIL behavior offline. Expand only after fit is real.

Shared posture Local verification · Replayable receipts · Deterministic outcomes · Procurement-ready review

Three entry points

One proof language. Three buyer-readable starts.

These are not disconnected products. They are focused entry surfaces into the same control posture: verify, permit, gate, and record evidence before consequential effect.

HALTSEALRuntime actionPre-action control

Where output becomes side effect

Pre-action enforcement at non-bypassable control points for agent execution, tool use, and downstream action.

ControlsVerifier → permit → gate at the runtime boundary.
Best startHyperscale, model-runtime, agent platform, or control-plane owners.
Pilot winNo permit, no side effect. PASS / HOLD / DENY behavior proven offline.
KingdomConformanceVendor-neutral

Deterministic validators and portable conformance

Conformance packs, replayable receipts, and procurement-readable PASS / FAIL / HOLD behavior for serious evaluation paths.

ControlsAcceptance tests, validators, and portable conformance evidence.
Best startSecurity, assurance, procurement, or vendors that need a neutral review surface.
Pilot winA portable pack with deterministic outputs that another party can replay and inspect.
Clinical Truth ChainClinicalRevenue cycle

Evidence that survives care and payment consequence

A clinical and revenue-cycle entry point where proof, continuity, and admissible automation matter more than presentation copy.

ControlsClinical and payment reliance surfaces that need receipts strong enough for independent review.
Best startHealth IT, medtech, imaging, monitoring, or revenue-cycle automation teams.
Pilot winPermit-to-pay and admissible automation evidence that can be replayed outside the vendor.
Shared posture

What all three share.

Regardless of entry product, the review pattern is the same: public-safe materials first, local verification where possible, deterministic evidence, and scoped diligence only when fit is real.

Verification

Local verification first

Serious buyers should be able to inspect artifacts themselves instead of depending on screenshots or vendor claims.

Evidence

Replayable receipts

Evidence is designed to survive independent review, procurement questions, and counsel scrutiny.

Behavior

Deterministic outcomes

PASS / HOLD / FAIL style behavior makes acceptance criteria legible before a production conversation starts.

Diligence

Public-safe outside, scoped depth under NDA

The public surface stays narrow. Integration detail, claim depth, and buyer-specific mapping appear only when fit is real.

Buyer map

Where serious buyers usually start.

The right move is not to pitch the whole stack. It is to start at the boundary the buyer already owns.

Hyperscale · runtime · infra

Start with HALTSEAL

Use the runtime-action lane when delegated execution, tool use, network egress, or downstream actuation are the real boundary.

Security · assurance · procurement

Start with Kingdom

Use conformance packs when the first question is not product messaging but what another party can verify and accept.

Health IT · medtech · revenue cycle

Start with Clinical Truth Chain

Use CTC when care delivery, payment consequence, or regulated operational reliance is the boundary that must be proven.

Design-partner pattern

How disciplined product motion should start.

Keep the first conversation narrow, verifiable, and operationally legible.

1

Choose one gateway

Pick the boundary that already controls real side effects or real reliance.

2

Agree receipts and acceptance tests

Define reason codes, expected behavior, and what PASS / HOLD / FAIL really means.

3

Verify offline first

Prove the evidence path and deterministic behavior before broader integration discussions.

4

Expand only where fit is real

Widen scope after the boundary, evidence, and buyer path have all actually landed.

Routes

From product interest to real diligence.

Each route should feel inevitable: verify, inspect, procure, then go deeper only where needed.

Verify

Inspect the live proof posture

Start with local verification and the trust surfaces that outrank page copy.

Procurement

Move into buyer-readable materials

Bring the conversation into acceptance criteria, conformance, and procurement-ready packets.

Patents

See the protected architecture

When the runtime-control story matters, the patents page shows the issued anchors and NDA boundary cleanly.

Company

Understand the mission and the surface

Buyers, partners, and press should see the same conviction: proof before consequential action.

Patents & licensing

Need the protected architecture view?

The HALTSEAL / NOVACOV runtime-control lane is now anchored by two issued U.S. grants on record: US 12,602,481 B1 and US 12,608,476 B1. The public site stays narrow by design; deeper diligence begins under NDA.

Product pages are informational only. No patent license by publication.